Cargando…
Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate‐to‐severe asthma
BACKGROUND: Current biologic therapies target allergic, eosinophilic or type 2 inflammation phenotypic asthma. However, frequency and degree of overlap among these subtypes is unclear. OBJECTIVE: To characterize overlap among allergic, eosinophilic and type 2 asthma phenotypes. METHODS: Post hoc ana...
Autores principales: | Chen, Meng, Shepard, Kirk, Yang, Ming, Raut, Pranil, Pazwash, Hooman, Holweg, Cecile T.J., Choo, Eugene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048421/ https://www.ncbi.nlm.nih.gov/pubmed/33217063 http://dx.doi.org/10.1111/cea.13790 |
Ejemplares similares
-
Age of asthma onset does not impact the response to
omalizumab
por: Rogers, Linda, et al.
Publicado: (2023) -
Interleukin-13 in Asthma and Other Eosinophilic Disorders
por: Doran, Emma, et al.
Publicado: (2017) -
Eosinophilic Inflammation in Allergic Asthma
por: Possa, Samantha S., et al.
Publicado: (2013) -
Real-Life Performance of Mepolizumab in T2-High Severe Refractory Asthma with the Overlapping Eosinophilic-Allergic Phenotype
por: González-Pérez, Ruperto, et al.
Publicado: (2022) -
Characteristics of Allergic, Eosinophilic, and Overlapping Asthma Phenotypes Among Pediatric Patients with Current Asthma: A Cross-Sectional Study from Saudi Arabia
por: Asseri, Ali Alsuheel
Publicado: (2023)